Related Experiment Video
Updated: May 9, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Taste alterations in breast cancer patients undergoing chemotherapy: an observational study
Andrea Devecchi1,2, Valentina Casalone3, Valentina Ponzo2
1University of Gastronomic Sciences of Pollenzo, Pollenzo, Italy.
Background:
Taste alterations are a common adverse effect of chemotherapy and may substantially impair quality of life, social interactions, and dietary habits. Reported incidence rates vary widely, partly due to the heterogeneity of assessment methods. This study aimed to investigate chemotherapy-induced taste alterations in patients with breast cancer using both objective (taste strips) and subjective (questionnaire-based) measures.
Materials And Methods:
This was a prospective study conducted between July 2023 and June 2025 at the Candiolo Cancer Institute FPO-IRCCS, in Torino (Italy). Sociodemographic, clinical, anthropometric variables, and dietary habits were collected. Taste alterations were evaluated using both subjective and objective assessment tools (taste strips).
Results:
A total of 94 female patients were enrolled. Of these, 70 patients had completed chemotherapy and taste evaluation and were included in the statistical analyses. According to subjective assessment, all taste modalities were significantly altered from pre- to post-chemotherapy evaluation, whereas one third of patients exhibited taste impairment when assessed using taste strips. The two methods showed limited agreement. In multiple regression models adjusted for age, smoking status, and pack-years, higher education level was inversely associated with subjective deterioration in sour (β = -0.49; 95% CI -0.82, -0.16; p = 0.006) and bitter taste perception (β = -0.47; 95% CI -0.79, -0.13; p = 0.006). Moreover, carbohydrate intake was inversely associated with worsening of overall taste perception (β = -1.96; 95% CI -3.72, -0.20; p = 0.035), as well as sour (β = -2.05; 95% CI -4.01, -0.09; p = 0.044) and salty taste perception (β = -1.92; 95% CI -3.76, -0.04; p = 0.046), based on subjective assessment.
Conclusion:
Taste alterations affect a substantial proportion of patients with breast cancer undergoing chemotherapy. The low agreement observed between subjective and objective measures suggests that these methods may assess distinct aspects of taste dysfunction and should be interpreted accordingly.
Related Concept Videos
Taste Buds and Receptors
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Cancer Prevention
Some...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
